Angiotensin receptors: Form and function and distribution

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 6, 2003, Pages 774-779

  Thomas, Walter G ^a   Mendelsohn, Frederick A O ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin II; Angiotensin IV; AT 1 , AT 2 , and AT 4 receptors; IRAP

Indexed keywords

AMINOPEPTIDASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II [3-8]; G PROTEIN COUPLED RECEPTOR; INSULIN REGULATED AMINOPEPTIDASE; UNCLASSIFIED DRUG;

BINDING AFFINITY; BINDING SITE; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW;

EID: 0037409311     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00263-7     Document Type: Short Survey

References (15)

1. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52:2000;415-472.
2. Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M., Chai S.Y. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 276:2001;48623-48626.
3. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science. 289:2000;739-745.
4. Curnow K.M., Pascoe L., Davies E., White P.C., Corvol P., Clauser E. Alternatively spliced human type 1 angiotensin II receptor mRNAs are translated at different efficiencies and encode two receptor isoforms. Mol. Endocrinol. 9:1995;1250-1262.
5. Xu K., Murphy T.J. Reconstitution of angiotensin receptor mRNA down-regulation in vascular smooth muscle. Post-transcriptional control by protein kinase a but not mitogenic signaling directed by the 5′-untranslated region. J. Biol. Chem. 275:2000;7604-7611.
6. Qian H., Pipolo L., Thomas W.G. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization. Mol. Endocrinol. 15:2001;1706-1719.
7. Rogi T., Tsujimoto M., Nakazato H., Mizutani S., Tomoda Y. Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family. J. Biol. Chem. 271:1996;56-61.
8. Yamahara N., Nomura S., Suzuki T., Itakura A., Ito M., Okamoto T., Tsujimoto M., Nakazato H., Mizutani S. Placental leucine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy. Life Sci. 66:2000;1401-1410.
9. Ryu J., Sik Hah J., Park J.S., Lee W., Rampal A.L., Jung C.Y. Protein kinase C-zeta phosphorylates insulin-responsive aminopeptidase in vitro at Ser-80 and Ser-91. Arch. Biochem. Biophys. 403:2002;71-82.
10. Sbodio J.I., Lodish H.F., Chi N.W. Tankyrase-2 oligomerizes with tankyrase-1 and binds to both TRF1 (telomere-repeat-binding factor 1) and IRAP (insulin-responsive aminopeptidase). Biochem. J. 361:2002;451-459.
11. 1 ) angiotensin II receptors provided by gene targeting. Trends Endocrinol. Metab. 11:2000;263-269.
12. Eguchi S., Dempsey P.J., Frank G.D., Motley E.D., Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J. Biol. Chem. 276:2001;7957-7962.
13. Thomas W.G., Brandenburger Y., Autelitano D.J., Pham T., Qian H., Hannan R.D. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ. Res. 90:2002;135-142.
14. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8:2002;35-40.
15. Crone S.A., Zhao Y.Y., Fan L., Gu Y., Minamisawa S., Liu Y., Peterson K.L., Chen J., Kahn R., Condorelli G., Ross J. Jr., Chien K.R., Lee K.F. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat. Med. 8:2002;459-465.